Health Canada
- Status: approved
🇨🇦 Intravenous Dexmedetomidine infusion in Canada
Intravenous Dexmedetomidine infusion (Intravenous Dexmedetomidine infusion) regulatory status in Canada.
Marketing authorisation
Intravenous Dexmedetomidine infusion in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Intravenous Dexmedetomidine infusion approved in Canada?
Yes. Health Canada has authorised it.
Who is the marketing authorisation holder for Intravenous Dexmedetomidine infusion in Canada?
Shaheed Mohtarma Benazir Bhutto Institue of Trauma is the originator. The local marketing authorisation holder may differ — check the official source linked above.